Evidence map›Paper›PMID 27337029›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2017

Comprehensive genetic analysis of pregnancy loss by chromosomal microarrays: outcomes, benefits, and challenges.

Trilochan Sahoo, Natasa Dzidic, Michelle N Strecker, Sara Commander, Mary K Travis, Charles Doherty, R Weslie Tyson, Arturo E Mendoza, Mary Stephenson, Craig A Dise and 3 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 3 pooled it
50.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 3 syntheses or guidelines pooled it, 206 citations in OpenAlex.

  1. Copy number variations in spontaneous abortions: a meta-analysis.Journal of assisted reproduction and genetics · 2025
    Pooled it
  2. Pooled it
  3. Genetic abnormalities and pregnancy loss.Seminars in perinatology · 2019
    Pooled it
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Trilochan SahooCombiMatrix Diagnostics, Irvine, California, USA.
Natasa DzidicCombiMatrix Diagnostics, Irvine, California, USA.ORCID 0000-0003-3893-3765
Michelle N StreckerCombiMatrix Diagnostics, Irvine, California, USA.ORCID 0000-0003-3401-6097
Sara CommanderCombiMatrix Diagnostics, Irvine, California, USA.
Mary K TravisCombiMatrix Diagnostics, Irvine, California, USA.
Charles DohertyCombiMatrix Diagnostics, Irvine, California, USA.
R Weslie TysonDepartment of Pathology, SCL Health System, Denver, Colorado, USA.ORCID 0000-0003-1754-7857
Arturo E MendozaDepartment of Pathology, Sharp Memorial Hospital, San Diego, California, USA.
Mary StephensonDepartment of Obstetrics and Gynecology, University of Illinois Hospital, Chicago, Illinois, USA.
Craig A DiseMorristown Medical Center, Morristown, New Jersey, USA.ORCID 0000-0002-7678-234X
Carlos W BenitoMorristown Medical Center, Morristown, New Jersey, USA.
Mandolin S ZiadieMemorial Regional Hospital, Hollywood, Florida, USA.
Karine HovanesCombiMatrix Diagnostics, Irvine, California, USA.ORCID 0000-0002-3844-0613
CombiMatrix · USMemorial Regional Hospital · USMorristown Medical Center · USSharp Memorial Hospital · USSt. Vincent's HealthCare · USUniversity of Illinois Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeChromosomal microarray analysis (CMA) is currently considered first-tier testing in pediatric care and prenatal diagnosis owing to its high diagnostic sensitivity for chromosomal imbalances. The aim of this study was to determine the efficacy and diagnostic power of CMA in both fresh and formalin-fixed paraffin-embedded (FFPE) samples of products of conception (POCs).

methodsOver a 44-month period, 8,118 consecutive samples were received by our laboratory for CMA analysis. This included both fresh (76.4%) and FFPE samples (22.4%), most of which were ascertained for recurrent pregnancy loss and/or spontaneous abortion (83%). The majority of samples were evaluated by a whole-genome single-nucleotide polymorphism (SNP)-based array (81.6%); the remaining samples were evaluated by array-comparative genomic hybridization (CGH).

resultsA successful result was obtained in 7,396 of 8,118 (91.1%), with 92.4% of fresh tissue samples and 86.4% of FFPE samples successfully analyzed. Clinically significant abnormalities were identified in 53.7% of specimens (3,975 of 7,396), 94% of which were considered causative.

conclusionAnalysis of POC specimens by karyotyping fails in 20-40% of cases. SNP-based CMA is a robust platform, with successful results obtained in >90% of cases. SNP-based CMA can identify aneuploidy, polyploidy, whole-genome homozygosity, segmental genomic imbalances, and maternal cell contamination, thus maximizing sensitivity and decreasing false-negative results. Understanding the etiology of fetal loss enables clarification of recurrence risk and assists in determining appropriate management for future family planning.Genet Med 19 1, 83-89.

Indexed as

Genetic TestingPrenatal DiagnosisAbortion, SpontaneousAdultAge FactorsAneuploidyChromosome AberrationsComparative Genomic HybridizationFemaleHumansIn Situ Hybridization, FluorescenceKaryotypingMiddle AgedParaffin EmbeddingPolymorphism, Single NucleotidePregnancy

Identifiers

PMID27337029
OpenAlexW2470310436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.